This study also aimed to investigate the association between cognitive decline and plasma BDNF concentrations in patients diagnosed with AD and MCI and to assess if plasma BDNF concentrations might be used as a biomarker of cognitive decline. This evidence concerns the gene BDNF and Alzheimer disease.